ViewRay

@viewray

ViewRay is a medical device company focused on developing a simultaneous MRI-guided adaptive radiation therapy technology for the treatment of cancer

Cleveland, OH
Vrijeme pridruživanja: travanj 2014.

Tweetovi

Blokirali ste korisnika/cu @viewray

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @viewray

  1. proslijedio/la je Tweet

    'The IAEA is ready to make treatment available in more countries'.

    Poništi
  2. prije 2 sata

    February 4 marks the 20th anniversary of . ViewRay encourages everyone to stand up, speak up and step up for a brighter future.

    Poništi
  3. prije 20 sati
    Poništi
  4. proslijedio/la je Tweet
    30. sij

    I was so fortunate to work with the fantastic Jacob Witt () and Michael Bassetti on this MR-guided Liver SBRT paper! Check it out in Lancet Oncology!

    Poništi
  5. 30. sij
    Poništi
  6. proslijedio/la je Tweet
    28. sij

    February 4th is ! There are a number of treatment options available for multiple cancer types, one of which is . We hope to bring awareness and provide information through resources like .

    Poništi
  7. 29. sij

    We are celebrating with today as they reach another milestone on . Congrats!

    Poništi
  8. proslijedio/la je Tweet
    25. sij

    Thanks for highlighting our recent MRgRT work—characterizing MRIdian RayZR MLC positional accuracy for routine QA in Online Adaptive RT program with IC-Profiler

    Poništi
  9. 22. sij
    Poništi
  10. 21. sij

    Today we celebrate the team at LMU Munich as they treat their first patients on their new !

    Poništi
  11. 21. sij

    Dr. Michael Haas of McGlinn Cancer Institute at Reading Hospital, Tower Health shares how they are revolutionizing treatment with the addition of their new , giving more patients more tomorrows.

    Poništi
  12. proslijedio/la je Tweet
    20. sij

    “Life’s most persistent and urgent question is, ‘What are you doing for others?'” - Martin Luther King, Jr. Words we try to live by everyday. Thank you for reminding us, Dr. King.

    Poništi
  13. 16. sij
    Poništi
  14. 14. sij
    Poništi
  15. 13. sij

    We're already seeing great advancements with at Oxford on their . Congrats!

    Tweet je nedostupan.
    Poništi
  16. 9. sij
    Poništi
  17. 9. sij

    We're seeing great news coming from this week — the five-year survival rate for pancreatic cancer has risen to 10% which is truly significant and shows the hard work and dedication of so many clinicians and researchers in the fight against cancer.

    Poništi
  18. 3. sij

    Congrats to the team at Washington University for having one of ASTRO's top-cited journal articles of the decade!

    Poništi
  19. 30. pro 2019.

    As 2019 comes to a close, we celebrate a great year and great advancements in cancer treatment like those at .

    Poništi
  20. 20. pro 2019.

    Today we celebrate a wonderful milestone for the team at University Hospital Zurich — 100 patients treated and 345 adaptive treatments completed on ! Your hard work and dedication to fighting cancer gives more patients more tomorrows.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·